GWM
AGN

Graybill Wealth Management’s Allergan plc AGN Stock Holding History

Graybill Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,800
Closed -$3.34M – 51
2019
Q1 		$3.34M Buy
22,800
+187
+0.8% +$27.1K 2.33% 24
2018
Q4 		$3.02M Sell
22,613
-2,075
-8% -$340K 2.52% 18
2018
Q3 		$4.7M Sell
24,688
-105
-0.4% -$19.3K 3.41% 3
2018
Q2 		$4.13M Sell
24,793
-400
-2% -$64.2K 3.17% 5
2018
Q1 		$4.24M Buy
25,193
+6,737
+37% +$1.13M 3.23% 7
2017
Q4 		$3.02M Buy
18,456
+305
+2% +$54.7K 2.18% 25
2017
Q3 		$3.72M Buy
18,151
+265
+1% +$61.6K 2.75% 10
2017
Q2 		$4.35M Buy
17,886
+251
+1% +$59K 3.44% 3
2017
Q1 		$4.21M Buy
17,635
+255
+1% +$59.4K 3.34% 3
2016
Q4 		$3.65M Buy
+17,380
New +$3.6M 3.11% 11

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Graybill Wealth Management's AGN Position: Q2 2019 in Review

Graybill Wealth Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 22,800 shares — an estimated $3.34M sold.

Graybill Wealth Management first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $4.7M in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Graybill Wealth Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Graybill Wealth Management sold 22,800 Allergan plc shares in Q2 2019, an estimated $3.34M.
  • Graybill Wealth Management first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • Graybill Wealth Management's Allergan plc position peaked at $4.7M in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Graybill Wealth Management's 13F filing for Q2 2019, filed 25 Jul 2019.